Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

Lantheus Holdings Inc (LNTH) USD0.01

Sell:$12.96 Buy:$12.98 Change: $0.03 (0.23%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:$12.96
Buy:$12.98
Change: $0.03 (0.23%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
Sell:$12.96
Buy:$12.98
Change: $0.03 (0.23%)
Market closed |  Prices as at close on 23 October 2020 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Lantheus Holdings, Inc. is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging. It operates in two segments: U.S. Segment and International Segment. The U.S. Segment produces and markets its medical imaging agents and products throughout the United States. In the United States, it sells its products to radiopharmacies, integrated delivery networks, hospitals, clinics and group practices. The International Segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. Its portfolio of nine commercial products is diversified across a range of imaging modalities. Its products include an ultrasound contrast agent and medical radiopharmaceuticals.

Contact details

Address:
331 Treble Cove Rd
NORTH BILLERICA
01862-2849
United States
Telephone:
+1 (978) 6718001
Website:
www.lantheus.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
LNTH
ISIN:
US5165441032
Market cap:
$837.17 million
Shares in issue:
66.81 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Mary Heino
    President, Chief Executive Officer, Director
  • Robert Marshall
    Chief Financial Officer, Treasurer
  • John Bolla
    Chief Operating Officer, Senior Vice President, Technical Operations
  • Michael Duffy
    Senior Vice President, Law and Public Policy and General Counsel
  • Etienne Montagut
    Senior Vice President - Corporate Development
  • Simon Robinson
    Senior Vice President - Research and Pharmaceutical Development
  • Carol Walker
    Senior Vice President - Quality
  • Paul Blanchfield
    Chief Commercial Officer
  • Istvan Molnar
    Chief Medical Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.